JAK-STAT pathway in carcinogenesis: Is it relevant to cholangiocarcinoma progression

doi:10.3748/wjg.v13.i48.6478

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 48

This Article

(0)

(8346)

(18)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Gastroenterol. Dec 28, 2007; 13(48): 6478-6491
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6478

Table 1 Cholangiocyte receptors associated with the JAK-STAT signaling pathways: alterations of expression during cholangiocarcinoma predisposition and development

Receptor type	Norma	Direction of alteration		References
Receptor type	Norma	Cholangiocarcinoma predisposition	Cholangiocarcinoma development
Prolactin receptor	Low	Up	Up Up	References	[7,58,148]
IL-6 receptor/gp130	Present	Up	Up Up	[2,5]
ErbB-2	Low/Absent	Up	Up Up	[2,138-140]
c-Met	Present	Up	Up Up	[2,5]
Growth hormone receptor	Moderate	Up	?	[72]
Leptin receptor	Present	?	?	[85]

Full Size Table

Citation: Smirnova OV, Ostroukhova TY, Bogorad RL. JAK-STAT pathway in carcinogenesis: Is it relevant to cholangiocarcinoma progression. World J Gastroenterol 2007; 13(48): 6478-6491
URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6478.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6478

Smirnova OV, Ostroukhova TY, Bogorad RL. JAK-STAT pathway in carcinogenesis: Is it relevant to cholangiocarcinoma progression. World J Gastroenterol 2007; 13(48): 6478-6491 [PMID: 18161917 DOI: 10.3748/wjg.v13.i48.6478]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.